Northern Trust Corp 2seventy Bio, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 402,613 shares of TSVT stock, worth $1.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

402,613

Previous 413,969 2.74%

Holding current value

$1.42 Million

Previous $1.59 Million 19.27%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$3.85 - $5.05 $43,720 - $57,347	-11,356 Reduced 2.74%	402,613 $1.9 Million
Q2 2024 Aug 14, 2024	SELL	$3.6 - $5.79 $38,473 - $61,877	-10,687 Reduced 2.52%	413,969 $1.59 Million
Q1 2024 May 14, 2024	BUY	$3.09 - $6.0 $17,486 - $33,954	5,659 Added 1.35%	424,656 $2.27 Million
Q4 2023 Feb 13, 2024	SELL	$1.57 - $4.58 $49,896 - $145,556	-31,781 Reduced 7.05%	418,997 $1.79 Million
Q3 2023 Nov 13, 2023	SELL	$3.14 - $11.2 $22,218 - $79,251	-7,076 Reduced 1.55%	450,778 $1.77 Million
Q2 2023 Aug 11, 2023	BUY	$8.45 - $12.48 $911,383 - $1.35 Million	107,856 Added 30.82%	457,854 $4.63 Million
Q1 2023 May 15, 2023	SELL	$9.21 - $14.98 $69,728 - $113,413	-7,571 Reduced 2.12%	349,998 $3.57 Million
Q4 2022 Feb 13, 2023	BUY	$8.57 - $17.0 $119,448 - $236,946	13,938 Added 4.06%	357,569 $3.35 Million
Q3 2022 Nov 14, 2022	SELL	$12.56 - $17.54 $47,841 - $66,809	-3,809 Reduced 1.1%	343,631 $5 Million
Q2 2022 Aug 12, 2022	BUY	$10.55 - $18.81 $1.33 Million - $2.37 Million	126,092 Added 56.97%	347,440 $4.59 Million
Q1 2022 May 13, 2022	SELL	$11.67 - $26.72 $17,878 - $40,935	-1,532 Reduced 0.69%	221,348 $3.78 Million
Q4 2021 Feb 08, 2022	BUY	$13.77 - $42.56 $3.07 Million - $9.49 Million	222,880 New	222,880 $5.71 Million

Others Institutions Holding TSVT

# of Institutions

126

Shares Held

45.6M

Call Options Held

122K

Put Options Held

19.8K

View Full List

About 2seventy bio, Inc.

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $133M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

More about TSVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp 2seventy Bio, Inc. Transaction History